Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s diseaseShinji Saiki, Nobutaka Hattori, Taku Hatano et al.|Scientific Reports|2017Cited by 143
Serum caffeine and metabolites are reliable biomarkers of early Parkinson diseaseMotoki Fujimaki, Nobutaka Hattori, Shin‐Ichi Ueno et al.|Neurology|2018Cited by 103
Parkinson’s disease-associated <i>iPLA2-VIA/</i> PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodelingAkio Mori, Nobutaka Hattori, Tsuyoshi Inoshita et al.|Proceedings of the National Academy of Sciences|2019Cited by 96